Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients

European Journal of Epidemiology

Volumn 12, Issue 1, 1996, Pages 91-92

  Amela, C ^a   Lopez Gay D ^b   Alberdi, J C ^b   Castilla, J ^a  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b Servicio de Epidemiología   (Spain)

Author keywords

AIDS; Injecting drug use; Leishmaniasis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SPAIN; VISCERAL LEISHMANIASIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; LEISHMANIASIS, VISCERAL; MALE; RISK FACTORS; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0029907316     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00144435     Document Type: Article

References (7)

1. Dereure J, Reynes F, Pratlong F, et al. Visceral leishmaniasis in HIV-infected patients in the south of France. Bull WHO 1995; 73: 245-246.
2. Altés J, Salas A, Riera M, et al. Visceral leishmaniasis: Another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS 1991; 5: 201-207.
3. Alvar J. Leishmaniasis and AIDS co-infection: The Spanish example. Parasitol Today 1994; 10: 160-163.
4. Consejería de Salud de la Comunidad de Madrid. Vigilancia epidemiológica del AIDS/VIH. Informe no. 14, October 1994.
5. Alvar J, Jiménez M. Could infected drug-users be potential Leishmania infantum reservoirs? [Letter]. AIDS 1994; 8: 854.
6. Molina R, Cañavate C, Cercenado E, et al. Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patient using colonized Phebotomus perniciosus. AIDS 1994; 10: 160-163.
7. Alvar J, Gutiérrez-Solar B, Molina R, et al. Prevalence of Leishmania infection among AIDS patients [Letter]. Lancet 1992; 339: 1427.